About Microbionical About Founded 2009. Business idea: Commercialize Seek & Heal™ technology. ACO Läkemedel, Stockholm – pharmaceutical development.

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

Immune System.
MRSA Community Acquired Methicillin Resistant Staphylococcus Aureus
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
Wound infection. Wound infection has a significant impact on economic and Patient outcomes (IWJ 2008), However it is often misdiagnosed and mistreated.
The Facts About MRSA.
What are Staph & MRSA? Staph (Staphlococcus aureus)
1 Review Describe how bacteria cause disease Review How do viruses cause disease Relate Cause and Effect Are vaccines effective before or after infection-
Control of Microbial Growth Tim Ho University of Alberta, Canada * The materials are mostly based on Dr. Brian Lanoil’s Microb Part.
1-19 © Th. Cherbuliez, M.D... Treatment of Wounds Description CMACC 2009 December 05 Th. Cherbuliez, MD.
MRSA.
Methicillin-resistant staphylococcus aureus By Jackson Cullop
20.3 Diseases Caused by Viruses and Bacteria
MRSA Methicillin Resistant Staphylococcus Aureus
1 Antimicrobial Therapy Chemotherapy: any treatment of patient with chemicals to treat a condition. –Now word associated with cancer treatment –Our focus.
Antibiotics and Antibiotic Resistance. Antibiotics Antibiotics are powerful medicines that fight bacterial infection Literal translation anti – against.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Safe Use of Antibiotics March 2011 (Simplified version)
MRSA PREPARED BY SARA ABUHIMED. Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These.
Proper Handwashing Clinical Rotation. CDC Centers for Disease Control Since person-to-person spread can play a significant role in the spread of some.
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Lesson Overview 20.3 Diseases Caused by Bacteria and Viruses.
Soft Tissue Infections
MRSA and VRE in a Rural Community Hospital Graduation Project 2008 Mehvish Ally.
Clindamycin induction test in treating patients infected with methicilin resistant Staphylococcus aureus Presented by Iyad Kaddora.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
Sterility, Asepsis and Universal Precautions Health Science Technology.
Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.
20.3 Bacterial & Viral Diseases pg Pathogen- microorganisms that cause disease 2 ways: 1. destroy living cells; tuberculosis- destroys lung tissue.
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Viral Diseases Some common human viral diseases are shown in the table.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 83 Basic Principles of Antimicrobial Therapy.
Chapter 20: Viruses and Prokaryotes
9/22/20151 ACCESS Human Biology. Disease Causing Micro organisms. Vera Harding.
MRSA 2006 Community Infection Control Nurses
Sterilization and Disinfection Dr. Wasif Haq. Concept & Need to Sterilize instruments Pakistan carries one of the world's highest burdens of chronic hepatitis.
Disease Test Vocabulary Terms Essay/Short Answer Question Review Challenge Questions.
© 2007 McGraw-Hill Higher Education. All rights reserved. Wound Care and Bloodborne Pathogens Amber Giacomazzi, MS, ATC.
Emerging Diseases Lecture 7: Antibiotics 7.1 Overview 7.2 Dr. Ehrlich’s Magic Bullet 7.3 Sulfa drugs 7.4 Antibiotics 7.5 Disambiguation.
Controlling Pathogens. How can we control pathogens to prevent disease?  Hygienic measures/Antiseptic Technique  Treatment of infections  Defence at.
CHEMISTRY 2000 Topics of Interest #1: Blowing up Bacteria with Nitrogen Monoxide (NO)
Diseases caused by Bacteria, Fungi and Viruses. Introduction  The body is constantly surrounded by microbes  It has many defence mechanisms to prevent.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
The Spread of Pathogens Starter 1. Why are most antibiotics no longer effective against MRSA? 2. Describe the pattern in Graph 1 and 2 3. Explain why deaths.
Pharmacology Unit 2: Applied Surgical Pharmacology Elsevier items and derived items © 2006 by Saunders, an imprint of Elsevier Inc.
Understanding Methicillin-Resistant Staphylococcus aureus
MEDICATIONS FOR INFECTION Principles of Antiseptic, Disinfectant, & Antimicrobial Therapy ADN 110/cohort 13 1.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Course Code: NUR 240 Lecture ( 3). 1.The Risk of Infection is always Present in every Hospital. 2.Identify frequency of nosocomial infection.
ASEPTIC TECHNIQUE IN HEALTHCARE. MICROBIAL GROWTH FOLLOWING FACTORS INFLUENCE MICROBIAL GROWTH: TEMPERATURE PH, OR THE VALUES USED IN CHEMISTRY TO EXPRESS.
Copyright (c) 2004 Elsevier Inc. All rights reserved. Basic Principles of Antimicrobial Therapy Chapter 79.
Gene therapy Lecture 8. What is a liposome? ◦ Spherical vesicles with a phospholipid bilayer Hydrophilic Hydrophobic.
Life and Times of: Methicillin Resistant Staphylococcus Aureus (MRSA) Group 3.
Lesson Overview Lesson Overview Diseases Caused by Bacteria and Viruses Lesson Overview 20.3 Diseases Caused by Bacteria and Viruses.
AktieTorgets investerarfrukost 17 september 2015 David Westberg, CEO.
The Efficacy of Topical Manuka Honey and Combination Antibiotic Therapy in the Treatment of MRSA Skin Infections Kyle Liban Pacific University School of.
Methicillin resistant Staphylococcus aureus. There are 2 types of MRSA: Community-acquired MRSA (CA-MRSA) This is passed throughout a community. You hear.
Nosocomial Antibiotic Resistant Organisms
Types of Sterilisation & Sanitation
ENVIRONMENTAL SCIENCE IN ENGINEERING
Diseases caused by bacteria and viruses
AptaSure™ - MRSA Point-Of-Care Infectious Disease Testing Device
Antibiotics and painkillers
Antimicrobial Agents and Immunology
Current Threats to Public Health
Biomaterials Dr. Ahmed Moro.
Presentation transcript:

About Microbionical About Founded Business idea: Commercialize Seek & Heal™ technology. ACO Läkemedel, Stockholm – pharmaceutical development NOVO-Nordisk, Copenhagen – enzyme surface chemistry EminTech, Helsingborg, Lund – pharmaceutical development Paul Persson – experience Think different: Instead of reformulation of tablets that were sensitive to moisture, Dr. Persson invented the drying tablet now found in many tube stoppers. Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Business background NMEs: Low probability of success One NME costs $ 1,5-1,8 US billions. 1 out of substances becomes a marketable product. New NMEs approved by FDA annually: 22. Generics High probability of pharmaceutical success. No commercial protection. New generics approved by FDA annually: >400. New formulations of well-known substances High probability of pharmaceutical success. Commercial protection (e.g. patent on drug delivery). New formulations approved by FDA 2010 :46 Pharma industry strategy to success Pharma industry has turned from NMEs (New Molecular Entities) to: Generics. New formulations of well-known substances. Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Drug targeting and/or drug release Drug release Well-known technology. Typical example: Delayed release of a drug from a slowly degrading polymer implant. Drug targeting – Aiming before shooting Emerging technology. Used mainly in cancer therapy: Increases concentration of drug at target tissue. Drug activity, but not side-effects, is increased. Well-known drug + targeting technology. Commercially protected product Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Drug targeting - Seek & Heal™ Bacteria show a different metabolism from that of healthy human tissue. Seek & Heal™ particles use this odd metabolism for identification, adhere to them, and then release the drug. The bacteria are therefore exposed to high concentrations of the drug, compared to the rest of the body. Mechanism Product Biomimetic (=imitates living matter) nanoparticles (=damn small) in a tissue friendly solution. The particles encapsulates a pharmaceutical drug. The particles selectively adheres to bacteria. Bacteria targeted by particles encapsulating a red dye after 0, 3, 6 and 26 hours. Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Microbial resistance towards antibiotics Threats to human health Antimicrobial resistance is one of the greatest threats to human health worldwide. The problem worsens each year. US hospital acquired infections cost annually $ million. MRSA 2006: Methicillin Resistant Staphylococcus aureus Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Use of Seek & Heal™ particles As bacteria becomes resistant towards antibiotics, this type of infection treatment is rapidly running out of hands. Prophylactic disinfection of surgical wounds Annual costs for surgical wound infections in USA is $ million. To prevent infection patients are treated prophylactically with antibiotics. If an infections still occurs, the patient is treated with additional antibiotics. Antiseptic substances are not used at hospitals because they harm human healthy tissue. Seek & Heal™ particles target only bacteria. Particles with encapsulated antiseptic hence makes it possible to kill normal of resistant bacteria, without harming human healthy tissue. Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Prophylactic disinfection of surgical wounds A liquid for washing surgical wounds before they are sewn. Bacteria are killed (normal or resistant). Healthy tissue and blood components are not damaged. The product disinfects the wound without influencing wound healing. Also other forms of wounds may be disinfected. Results in vitro: Seek & Heal™ kills bacteria. Seek & Heal™ does not harm blood. According to in vitro results, prophylactic disinfection of surgical wounds is possible. A new paradigm in wound care The product Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

Future possibilities for Seek & Heal™ Therapies for diseases in organs like sinuses, liver, spleen or kidneys. First generation products Keep it simple! External applications! Suitable substances for inclusion in Seek & Heal™ particles are e.g. antiseptics and antibiotics with restricted applicability. Injection therapies, targeting individual cells, or groups of cells: Against metastases. Contrast enhancement in MRI (paramagnetic materials). Second generation products Third generation products Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you

For further information, please visit Mail: Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you Contents About Microbionical Business background Drug targeting Background Seek & Heal™ Microbial resistance Use of Seek & Heal™ particles in wounds Future possibilities Thank you